Placental transmission of thyroid-stimulating immunoglobulins.
- 21 June 1975
- Vol. 2 (5972), 665-666
- https://doi.org/10.1136/bmj.2.5972.665
Abstract
Long-acting thyroid stimulator (LATS) and LATS protector (LATS-P) were assayed at or near delivery in serum from 18 pregnant women with a history of past or present thyrotoxicosis. The results suggested that neonatal thyrotoxicosis may be predicted prenatally if maternal serum LATS and LATS-P concentrations near delivery are above certain levels.Keywords
This publication has 7 references indexed in Scilit:
- Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.BMJ, 1975
- Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.1975
- PLACENTAL TRANSMISSION OF L.A.T.S.- PROTECTORThe Lancet, 1974
- SOME FACTORS AFFECTING THE DETECTION OF LONG-ACTING THYROID STIMULATOR PROTECTOR USING THE McKENZIE BIOASSAYJournal of Endocrinology, 1974
- THE INTERACTION OF THE LONG-ACTING THYROID STIMULATOR (LATS) WITH THYROID TISSUE IN VITROJournal of Endocrinology, 1970
- Occurrence in Thyrotoxicosis of a Gamma Globulin Which Protects LATS from Neutralization by an Extract of Thyroid GlandJournal of Clinical Endocrinology & Metabolism, 1967
- NEONATAL THYROTOXICOSIS ASSOCIATED WITH MATERNAL HYPOTHYROIDISMThe Lancet, 1966